The global mesoporous silica market size was valued at USD 152.7 million in 2020 and is expected to reach USD 281 million by grow at a compound annual growth rate (CAGR) of 9.12% from 2020 to 2027. Rising product penetration in different application industries, such as chemicals, wastewater treatment, and pharmaceuticals, drives the market. Thermal stability, favorable chemical properties, and biocompatibility attributes of the product are anticipated to boost its demand in the pharmaceutical industry over the forecast period.
Increasing and effective research & development activities for cancer treatment using Mesoporous silica are also expected to augment the product demand. A wide range of existing and potential applications of the product in drug delivery and wastewater treatment fields and extensive use in the chemical industry as a catalyst for the synthesis of various chemicals coupled with rising expenditure on biotechnology by the government and pharmaceutical firms are anticipated to bolster the product demand.
The market in China is expected to exhibit high growth on account of the rapid development of application industries. China is one of the potential regional markets for mesoporous silica owing to rapid industrialization and favorable pharmaceutical and chemical industry prospects. China has emerged as the global production hub for various industries, such as pharmaceuticals and chemicals, over the last three decades. A large number of multinational chemical and pharmaceutical companies have shifted their manufacturing operations to China owing to the easy availability of raw materials and favorable trade policies.
Strict regulations in Europe and North America are anticipated to hinder the market growth in these regions. Regulatory authorities, such as the Environmental Protection Agency (EPA) of the U.S. and the Health and Consumer Protection Directorate, are engaged in investigating the possible negative impacts of nano particles on the environment and thus on human health.
The MCM series segment led the global market in 2020 accounting for a revenue share of over 45%. The SBA series is projected to register the fastest CAGR over the forecast period on account of its use in diverse applications, such as pharmaceutical, chemical, and others.
The market is majorly segmented based on products into SBA series, MCM series, and other products. SBA includes SBA 15 and SBA 16 materials used from the SBA series exhibiting hexagonal and lamellar structures, respectively. The properties exhibited by the SBA series products, such as thermal and mechanical stability, high surface area, and ease of functionalization, propel their demand.
The drug delivery application segment led the market in 2020 and accounted for more than 44% of the global revenue share. The segment is projected to expand further at a steady CAGR from 2020 to 2027 owing to the burgeoning demand for Mesoporous silica materials in the pharmaceutical industry. Rapid advancements in the Mesoporous materials are further expected to broaden its application scope, thereby driving the product demand. Other applications include catalysis, environmental protection, and others.
The Mesoporous Silica Market is segmented on the basis of product, application and region. On the basis of product MCM Series, SBA Series, Others. On the basis of application Catalysis, Drug Delivery, Environmental Protection, Others.
North America led the market and accounted for a 36% share of the global revenue in 2020 owing to the rapid growth of the pharmaceutical industry and increasing expenditure on wastewater treatment. Rapid industrialization, growing environmental concerns, and stringent regulations set by various governments to maintain environmental quality are anticipated to promote the implementation of wastewater treatment processes, thereby, propelling the use of mesoporous silica over the forecast period.
The rise in the research & development process of mesoporous silica to explore potential products and their applications in various end-use industries, increased utilization of nanotechnology in biomedical and other applications are projected to boost the market growth in the region over the forecast period.
The market in Europe is expected to grow at a significant rate over the forecast period, which can be attributed to rising product demand from the pharmaceutical industry. The pharmaceutical industry is one of the significant contributors to the region’s economy. However, the U.K.’s exit from the European Union is expected to have a major impact on the growth of the pharmaceutical industry restraining the market growth for mesoporous silica in the region.
Central & South America (CSA) is anticipated to witness slower growth. Even though the market has growth capabilities owing to the availability of inexpensive labor and floor space for manufacturing and research facilities, the political instability in the region is expected to restrain the growth.
Key companies are: Merck KGaA; American Elements; Nanocomposix, Inc.; Taiyo International; Mitsubishi Chemical Corporation; MKnano; W.R.Grace& Co.; AGC Chemicals Americas, Inc.; Glantreo Ltd.; ACS Material LLC.
Report : Mesoporous Silica Market - By Product (MCM Series, SBA Series, Others) By Application (Catalysis, Drug Delivery, Environmental Protection, Others) By Region (North America, Europe, Asia Pacific, South America, Middle East and Africa) - Industry Analysis, Opportunity and Forecast 2020 To 2027.